215 results on '"Thomalla, J"'
Search Results
2. Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response
3. Corrigendum to “A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study”
4. P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FROM THE GMMG-HD7 TRIAL
5. Curricular course for medical students at a hematology and oncology specialty practice, 2010-2022
6. Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response
7. A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study (vol 30, pg 1279, 2019)
8. Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
9. Evaluation of psychosocial distress in patients treated in a community-based oncology group practice in Germany
10. Metastatic breast cancer: Improving survival in routine care by targeted therapies: ID 130
11. Identification of a gene frequently mutated in prostate tumors
12. Routine care of patients with multiple myeloma in a community based oncology group practice in Germany 1995-2010: V770
13. Evaluation of psychosocial distress in main care-givers of patients with a metastatic solid tumor who receive treatment in a community based oncology group practice: V401
14. The impact of new treatment options for advanced colorectal cancer on routine care: results of a retrospective analysis of 206 consecutive patients treated in a community-based oncology group practice in Germany
15. Evaluation of important contact persons and their helpfulness in coping with psycho-social distress induced by metastatic solid tumors. A prospective study at a community-based oncology group practice in Germany: FV215
16. European multi-centre, open-label phase III study of sorafenib in European pts with advanced RCC (EU-ARCCS) - Final analysis: V859
17. Incidental living donor nephrectomy: a unique expansion of the donor pool
18. Survival of patients with advanced solid tumours who are treated in community based oncology group practices is longer compared to registry data and comparable to randomized controlled trials
19. Abstract PD2-07: mRNA signatures predict response to durvalumab therapy in triple negative breast cancer (TNBC)– Results of the translational biomarker programme of the neoadjuvant double-blind placebo controlled GeparNuevo trial
20. Abstract PD5-05: Pre-therapeutic PD-L1 expression and dynamics of Ki-67 and gene expression during neoadjuvant immune-checkpoint blockade and chemotherapy to predict response within the GeparNuevo trial
21. Abstract P1-16-06: Improved survival of patients with metastatic breast cancer in routine care is restricted to tumors with positive hormone receptor and/or Her2-expression. Survival analysis of 1,321 patients treated between 1995 and 2017 in oncology group practices
22. Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
23. A randomised phase III trial comparing two dose-dense, dose-intensified approaches (ETC and PM(Cb)) for neoadjuvant treatment of patients with high-risk early breast cancer (GeparOcto)
24. Abstract P6-15-01: Withdrawn
25. Die Versorgungsrealität von Patienten mit Multiplem Myelom nach Hochdosistherapie und autologer Stammzelltransplantation in einer Schwerpunktpraxis für Hämatologie und Onkologie 2006 - 2016
26. Die Versorgungsrealität von therapiebedürftigen Patienten mit Chronisch Lymphatischer Leukämie (CLL) in einer Schwerpunktpraxis für Hämatologie und Onkologie
27. Nachsorgerealität von Brustkrebspatientinnen – standardisierte Befragung von Patientinnen und Ärzten sowie Analyse der Behandlungsdaten
28. Abstract P5-16-01: A randomised phase III trial comparing two dose-dense, dose-intensified approaches (ETC and PM(Cb)) for neoadjuvant treatment of patients with high-risk early breast cancer (GeparOcto)
29. Die Versorgungsrealität von Patientinnen mit metastasiertem Mammakarzinom in einer onkologischen Schwerpunktpraxis
30. Compliance / Adhärenz von Patientinnen mit metastasiertem Mammakarzinom unter oraler Therapie: Wahrnehmung von Patientinnen, Angehörigen und Onkologen sowie Analyse der Verordnungsdaten
31. Hypospadias repair in elderly patients
32. Immunglobulin-Substitution bei Patienten mit indolenten Non-Hodgkin-Lymphomen
33. Follow-up Reality for Breast Cancer Patients – Standardised Survey of Patients and Physicians and Analysis of Treatment Data
34. Abstract P4-10-13: Follow-up care of breast cancer patients who were treated in a German breast cancer centre - Survey of patients and attending physicians and analysis of treatment data
35. Die Versorgungsrealität von Patienten mit einer Immunthrombozytopenie (ITP) in einer Schwerpunktpraxis für Hämatologie und Onkologie
36. Curricular course for medical students at a hematology and oncology specialty practice, 2010-2022
37. Immunglobulinsubstitution in der Behandlung von Patienten mit follikulärem Lymphom oder Chronisch Lymphatischer Leukämie
38. Immunglobulin-Substitution bei Patienten mit indolenten Non-Hodgkin-Lymphomen
39. Nachsorge von Brustkrebspatientinnen, die in einem zertifizierten Brustzentrum behandelt wurden – standardisierte Patientenbefragung und Analyse der medizinischen Behandlungsdaten
40. Metastasiertes Mammakarzinom: Verbesserte Überlebensraten in der Routineversorgung durch zielgerichtete Therapien
41. Compliance/Adhärenz von Patientinnen mit metastasiertem Mammakarzinom unter oraler Therapie: Wahrnehmung von Patientinnen, Angehörigen und Onkologen sowie Analyse der Verordnungsdaten
42. Versorgungsforschung in einer Schwerpunktpraxis für Hämatologie und Onkologie im Zeitraum von 1998 bis 2008
43. Interactive medical education for medical students in an oncology group practice
44. Ovarian Cancer Treatment Reality in Northern Rheinland-Pfalz (Germany). Suboptimal surgical treatment as the cause for inferior survival. A Retrospective Study of 139 Patients Receiving Chemotherapy and Palliative Care in an Oncology Group Practice
45. Outpatient care in metastatic breast cancer
46. Nachsorgerealität von Brustkrebspatientinnen – standardisierte Befragung von Patientinnen und Ärzten sowie Analyse der Behandlungsdaten.
47. Versorgungsrealität von Patienten mit metastasiertem Nierenzellkarzinom (mRCC) in einer onkologischen Schwerpunktpraxis 2010 – 2013
48. Abstract P6-08-08: Adjuvant breast cancer therapy: Correlation of treatment data with patient reported outcomes in a German breast cancer centre
49. P-157 Routine care reality of patients with myelodysplastic syndromes who received diagnosis and treatment in a community-based oncology group practice in Germany
50. Interaktiver Kleingruppenunterricht für Medizinstudenten der Klinischen Semester in einer onkologischen Gemeinschaftspraxis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.